22 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
24 Jul 23
Regulation FD Disclosure
4:04pm
( Aurinia ) in 1997 and joined HEPA in 2016. Core R&D team has collectively 120 yrs of experience with cyclophilin inhibition drug development, most
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
22 May 23
Regulation FD Disclosure
1:05pm
) in 1997 and joined HEPA in 2016. Core R&D team has collectively 120 yrs of experience with cyclophilin inhibition drug development, most notably
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
17 Oct 22
Regulation FD Disclosure
5:13pm
Aspeslet , PhD COO Formerly COO of Isotechnika ( Aurinia ) from 1996 - 2013. Was CEO of an oncology CRO from 2013 until joining HEPA in 2022. Core R&D team
8-K
EX-99.1
suz8qb
28 Jun 22
Departure of Directors or Certain Officers
9:46am
10-KT
d76xojk
26 Mar 18
Annual report (with FYE transition)
12:00am